Thermo Fisher Scientific ...

NYSE: TMO · Real-Time Price · USD
485.13
0.34 (0.07%)
At close: Aug 14, 2025, 3:59 PM

Thermo Fisher Scientific Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
42.88B 42.86B 44.91B 39.21B
Cost of Revenue
25.15B 25.66B 25.9B 19.58B
Gross Profit
17.73B 17.19B 19.01B 19.63B
Operating Income
7.66B 7.45B 8.53B 10.32B
Interest Income
1.08B 879M 272M 43M
Pretax Income
7B 6.24B 7.66B 8.84B
Net Income
6.33B 6B 6.95B 7.72B
Selling & General & Admin
8.68B 8.41B 9.02B 7.91B
Research & Development
1.39B 1.34B 1.47B 1.41B
Other Expenses
n/a n/a n/a n/a
Operating Expenses
10.07B 9.75B 10.49B 9.32B
Interest Expense
1.65B 1.49B 726M 536M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
35.22B 35.41B 36.39B 28.89B
Income Tax Expense
657M 284M 703M 1.11B
Shares Outstanding (Basic)
382M 386M 392M 394M
Shares Outstanding (Diluted)
383M 388M 394M 397M
EPS (Basic)
16.58 15.53 17.73 19.61
EPS (Diluted)
16.53 15.45 17.64 19.46
EBITDA
11.8B 11.2B 11.94B 11.97B
EBIT
8.69B 7.79B 8.56B 9.38B
Depreciation & Amortization
3.11B 3.41B 3.38B 2.59B